Every SEC Form 3/4/5 on record for this filer (CIK 1697422) — 1 issuer, 157 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | EVP Finance CFO | 2017-03-02 → 2025-12-09 | 39 | −$30M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2024-08-28 | Sell | 928 | $1,205.49 | $1M | 450 |
| REGN | 2024-08-28 | Sell | 235 | $1,205.67 | $283,332 | 225 |
| REGN | 2024-08-28 | Sell | 200 | $1,206.70 | $241,340 | 25 |
| REGN | 2024-08-28 | Sell | 236 | $1,205.67 | $284,538 | 225 |
| REGN | 2024-08-28 | Sell | 450 | $1,206.15 | $542,768 | — |
1 of 1 issuers are covered and open a security page; the rest are on file here only.